Morphine Patient & Medical Information

Morphine is the prototypical strong opioid analgesic derived from the opium poppy. It remains the gold standard against which all other opioids are measured and is essential for managing moderate-to-severe cancer pain and post-operative pain.

As a Schedule II controlled substance, morphine carries risk of dependence but is included on the WHO Essential Medicines List. It is available in multiple formulations: oral immediate-release, extended-release, intravenous, subcutaneous, and suppository.

Mechanism of Action

Morphine acts primarily through mu-opioid receptors (µ), with secondary effects at kappa (κ) and delta (δ) receptors throughout the central and peripheral nervous system. Receptor binding inhibits adenylate cyclase, reduces cAMP, and decreases neuronal excitability.

The drug suppresses cough reflex, reduces GI motility, and induces histamine release. Spinal cord dorsal horn inhibition and supraspinal effects (thalamus, periaqueductal gray) modulate both sensory and affective components of pain.

Indications & Use

Indicated for moderate-to-severe pain not adequately controlled by non-opioid analgesics. Primary uses include cancer pain, post-operative pain, trauma, myocardial infarction, and severe chronic pain in palliative care.

Also used for dyspnoea in terminal illness and as premedication before surgery. Oral formulations for chronic pain; parenteral routes for acute pain.

Dosage

Dosing is individualized based on pain intensity and opioid tolerance. Oral immediate-release: initially 5–10 mg every 4 hours; extended-release every 12 hours. IV doses are 2–4 mg due to higher bioavailability.

Elderly and renally/hepatically impaired patients require 25–50% dose reduction. Regular reassessment and titration are essential.

Side Effects

Most common: constipation (virtually universal—prophylactic laxatives mandatory), nausea, vomiting, sedation, pruritus. Respiratory depression is the most serious adverse effect, dose-dependent.

Other effects: urinary retention, cognitive impairment, hypotension, physical dependence. Long-term use may cause hypogonadism and hormonal changes.

Drug Interactions

CNS depressants (benzodiazepines, alcohol, other opioids, sedating antihistamines) potentiate respiratory depression—potentially fatal combination. MAO inhibitors contraindicated within 14 days.

CYP3A4 inducers (rifampicin) reduce efficacy; inhibitors (ketoconazole, ritonavir) increase plasma levels and toxicity risk.

Contraindications

Absolute contraindications: severe respiratory depression, paralytic ileus, acute/severe asthma, known hypersensitivity.

Use with caution in head trauma with raised ICP, adrenocortical insufficiency, severe renal/hepatic impairment, seizure disorders, or history of substance use disorder.

Frequently Asked Questions

Does morphine cause addiction?

Physical dependence develops with regular use. True addiction is rare in patients taking morphine for legitimate pain; risk increases with prolonged use and prior substance abuse history.

How quickly does morphine work?

Oral immediate-release: 30–60 minutes onset, peak at 1–2 hours. IV: acts within minutes. Extended-release: 2–4 hours to effective levels, maintains analgesia 8–12 hours.

Can I drive on morphine?

During titration, driving is strongly discouraged. Once stabilized and without somnolence, some patients may drive after medical evaluation. Morphine is listed as potentially affecting driving ability.

What if I overdose?

Call 911/emergency services immediately. Naloxone is the specific opioid antidote and is available in pharmacies without prescription for patient support networks.

References

EMA Assessment Report on opioid analgesics
WHO Model List of Essential Medicines, 23rd edition
Palliative Care Formulary (PCF7), 2023
AWMF S3-Leitlinie Palliativmedizin

Medical Disclaimer: This information is for educational purposes only and does not replace professional medical advice.